Highly Sensitive Detection of the IDH1 R132H Mutation in the Plasma of Glioma Patients

被引：0
|
作者：
Balaj, Leonora
Carter, Bob S.
Castellanos-Rizaldos, Elena
Peruzzi, Pier Paolo
Chan, Dalin
Zhang, Xuan
Skog, Johan
机构：
来源：
NEUROSURGERY | 2018年 / 65卷
关键词：
D O I：
10.1093/neuros/nyy303.309
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
309
引用
收藏
页码：125 / 126
页数：2
相关论文
共 50 条
  • [41] Detection of IDH1 (R132H) Mutations in Acute Myeloid Leukemia (AML) By Immunohistochemistry
    Redd, Lucas
    Schmidt, Yao
    Oliver, Dwight
    Koduru, Prasad
    Luu, Hung
    Chen, Weina
    LABORATORY INVESTIGATION, 2015, 95 : 373A - 373A
  • [42] Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors
    Capper, David
    Weissert, Susanne
    Balss, Joerg
    Habel, Antje
    Meyer, Jochen
    Jaeger, Diana
    Ackermann, Ulrike
    Tessmer, Claudia
    Korshunov, Andrey
    Zentgraf, Hanswalter
    Hartmann, Christian
    von Deimling, Andreas
    BRAIN PATHOLOGY, 2010, 20 (01) : 245 - 254
  • [43] Effects of the IDH1 R132H Mutation on the Energy Metabolism: A Comparison between Tissue and Corresponding Primary Glioma Cell Cultures
    Dekker, Lennard J. M.
    Verheul, Cassandra
    Wensveen, Nicky
    Leenders, William
    Lamfers, Martine L. M.
    Leenstra, Sieger
    Luider, Theo M.
    ACS OMEGA, 2022, 7 (04): : 3568 - 3578
  • [44] Absence of IDH1 R132H Mutation Predicts Rapid Progression of Non-Enhancing Diffuse Glioma in Older Adults
    Olar, A.
    Raghunathan, A.
    Albarracin, C. T.
    Aldape, K. D.
    Cahill, D. P.
    Powell, S. Z.
    Goodman, C.
    Fuller, G. N.
    LABORATORY INVESTIGATION, 2011, 91 : 383A - 384A
  • [45] DOES IDH1 R132H MUTATION ALTER PHOSPHOLIPID METABOLISM IN GLIOMA? A 31 P-MRS IN VIVO STUDY
    Wenger-Alakmeh, K. J.
    Pilatus, U.
    Baehr, O. R.
    NEURO-ONCOLOGY, 2016, 18 : 34 - 35
  • [46] THE ROLE OF IDH1 R132H MUTATION IN GLIOMA AN INVESTIGATION BY GENOME-EDITING IN HUMAN INDUCED PLURIPOTENT STEM CELLS
    Kopp, Alexander
    Gawehn, Luzie
    William, Doreen
    Preussler, Matthias
    Richter, Susan
    Heide, Michael
    Marrone, Lara
    Thieme, Anne
    Borgmann, Felix Kleine
    Mittelbronn, Michel
    Capper, David
    Schrock, Evelin
    Klink, Barbara
    NEURO-ONCOLOGY, 2021, 23 : 217 - 217
  • [47] Beyond IDH1 R132H mutation-Clinicopathological characteristics of non-canonical IDH mutant gliomas
    Martinez-Saez, E.
    Hernandez Lain, A.
    Vidal, N.
    Gama, J.
    Rivas, E.
    Taipa, R.
    Carrato, C.
    Pimentel, J.
    Ferrer-Lozano, J.
    Varela, M.
    Hernandez-Losa, J.
    Camacho-Soriano, J.
    Pinto, M.
    Rebelo, O.
    Roque, R.
    Ramon y Cajal, S.
    Toldos-Gonzalez, O.
    BRAIN PATHOLOGY, 2023, 33
  • [48] A Tale of Two Subunits: How the Neomorphic R132H IDH1 Mutation Enhances Production of αHG
    Pietrak, Beth
    Zhao, Huizhen
    Qi, Hongwei
    Quinn, Chad
    Gao, Enoch
    Boyer, Joseph G.
    Concha, Nestor
    Brown, Kristin
    Duraiswami, Chaya
    Wooster, Richard
    Sweitzer, Sharon
    Schwartz, Benjamin
    BIOCHEMISTRY, 2011, 50 (21) : 4804 - 4812
  • [49] Production Of IDH1 R132H Recombinant Protein In Escherichia Coli As Therapeutic Candidate And Development Of Stable Transfected IDH1 R132H Malaysian Recurrent Glioblastoma Cell Line
    Goh, Wei Chiang
    Ahmad, Farizan
    Shamsuddin, Shaharum
    Idris, Badrisyah
    WORLD FEDERATION OF NEUROSURGICAL SOCIETIES (WFNS SYMPOSIA 2018), 2018, : 223 - 231
  • [50] IMMUNOCYTOCHEMISTRY FOR THE PRODUCT OF THE R132H MUTATION OF IDH1 PREDICTS OUTCOME IN GLIOBLASTOMAS TREATED WITH CONCOMITANT CHEMORADIOTHERAPY
    Clark, B.
    Stewart, J.
    Mackinnon, M.
    Hanzely, Z.
    Rampling, R.
    von Deimling, A.
    Stewart, W.
    NEURO-ONCOLOGY, 2010, 12 : 2 - 2
12345